Literature DB >> 11898516

The treatment of tics.

H S Singer1.   

Abstract

Tics are the essential component of a variety of disorders, notably Tourette syndrome. Because the mere presence of tics does not require therapeutic intervention, criteria are essential for determining a functional disability. Suggested tic-suppressing treatments have been extremely diverse, including hydrotherapy, behavioral treatments, pharmacotherapy, botulinum toxin, immunomodulatory therapy, and surgery. This manuscript reviews each of these approaches with emphasis on more recent pharmacologic trials.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11898516     DOI： 10.1007/s11910-001-0016-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   6.030


  66 in total

1.  Short-term versus longer term pimozide therapy in Tourette's syndrome: a preliminary study.

Authors: 
Journal:  Neurology       Date:  1999-03-10       Impact factor: 9.910

2.  The trial use of clozapine for abnormal involuntary movement disorders.

Authors:  E D Caine; R J Polinsky; R Kartzinel; M H Ebert
Journal:  Am J Psychiatry       Date:  1979-03       Impact factor: 18.112

3.  Habit reversal for the treatment of Tourette syndrome.

Authors:  N H Azrin; A L Peterson
Journal:  Behav Res Ther       Date:  1988

4.  Sequential application of major habit-reversal components to treat motor tics in children.

Authors:  D W Woods; R G Miltenberger; V A Lumley
Journal:  J Appl Behav Anal       Date:  1996

5.  Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome.

Authors:  B L Scott; J Jankovic; D T Donovan
Journal:  Mov Disord       Date:  1996-07       Impact factor: 10.338

6.  Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.

Authors:  P B Chappell; M A Riddle; L Scahill; K A Lynch; R Schultz; A Arnsten; J F Leckman; D J Cohen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-09       Impact factor: 8.829

7.  Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.

Authors:  P J Lombroso; L Scahill; R A King; K A Lynch; P B Chappell; B S Peterson; C J McDougle; J F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-09       Impact factor: 8.829

8.  Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome.

Authors:  J Jankovic; D G Glaze; J D Frost
Journal:  Neurology       Date:  1984-05       Impact factor: 9.910

9.  Seven cases of Gilles de la tourette's syndrome: partial relief with clonazepam: a pilot study.

Authors:  M Gonce; A Barbeau
Journal:  Can J Neurol Sci       Date:  1977-11       Impact factor: 2.104

Review 10.  Tourette's syndrome and 'PANDAS': will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection.

Authors:  R Kurlan
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910
View more
  6 in total

1.  Centromedian-parafascicular deep brain stimulation induces differential functional inhibition of the motor, associative, and limbic circuits in large animals.

Authors:  Joo Pyung Kim; Hoon-Ki Min; Emily J Knight; Penelope S Duffy; Osama A Abulseoud; Michael P Marsh; Katherine Kelsey; Charles D Blaha; Kevin E Bennet; Mark A Frye; Kendall H Lee
Journal:  Biol Psychiatry       Date:  2013-08-30       Impact factor: 13.382

Review 2.  Pharmacological therapy for Tourette syndrome: What medicine can do and cannot do.

Authors:  Yoshiko Nomura
Journal:  Biomed J       Date:  2021-09-20       Impact factor: 7.892

3.  Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.

Authors:  Dean F Wong; James R Brasić; Harvey S Singer; David J Schretlen; Hiroto Kuwabara; Yun Zhou; Ayon Nandi; Marika A Maris; Mohab Alexander; Weiguo Ye; Olivier Rousset; Anil Kumar; Zsolt Szabo; Albert Gjedde; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2007-11-07       Impact factor: 7.853

Review 4.  Contemporary assessment and pharmacotherapy of Tourette syndrome.

Authors:  Lawrence Scahill; Gerald Erenberg; Cheston M Berlin; Cathy Budman; Barbara J Coffey; Joseph Jankovic; Louise Kiessling; Robert A King; Roger Kurlan; Anthony Lang; Jonathan Mink; Tanya Murphy; Samual Zinner; John Walkup
Journal:  NeuroRx       Date:  2006-04

5.  Centromedian-Parafascicular Complex Deep Brain Stimulation for Tourette Syndrome: A Retrospective Study.

Authors:  Paola Testini; Cong Z Zhao; Matt Stead; Penelope S Duffy; Bryan T Klassen; Kendall H Lee
Journal:  Mayo Clin Proc       Date:  2016-02       Impact factor: 7.616

6.  Neurosurgical strategies for Gilles de la Tourette's syndrome.

Authors:  Karim Mukhida; Matthew Bishop; Murray Hong; Ivar Mendez
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.